Alzamend Neuro
Research - Atlanta, Georgia, United States
Alzamend Neuro Employees
Alzamend Neuro Senior Management
Alzamend Neuro Details
Alzamend Neuro is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Our mission is to rapidly develop and market safe and effective treatments. Our current pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
Alzamend Neuro Technologies
Email Providers
Outlook
CMS
WordPress.org
Tag Management
Google Tag Manager
Web Accelerators
CloudFlare
Other
Mobile Friendly